SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5dqf'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1E7A_A_PFLA4001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 9 LEU A 386
ASN A 390
LEU A 406
ARG A 409
VAL A 432
GLY A 433
 None
 0.76A 1e7aA-5dqfA:
48.6		 1e7aA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1E7A_A_PFLA4001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 LEU A 547
ASN A 404
VAL A 423
GLY A 426
ALA A 529
 None
None
PG4  A 604 ( 4.9A)
None
None
 1.16A 1e7aA-5dqfA:
48.6		 1e7aA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1E7A_B_PFLB4001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 9 LEU A 386
ASN A 390
PHE A 402
LEU A 406
ARG A 409
VAL A 432
GLY A 433
 None
 0.79A 1e7aB-5dqfA:
49.7		 1e7aB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1E7A_B_PFLB4001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 9 LEU A 386
ASN A 390
PHE A 402
LEU A 406
VAL A 432
GLY A 433
LEU A 452
 None
 0.67A 1e7aB-5dqfA:
49.7		 1e7aB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1E7B_A_HLTA4003_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 9 ASN A 390
PHE A 402
LEU A 406
VAL A 432
GLY A 433
LEU A 452
 None
 0.70A 1e7bA-5dqfA:
46.6		 1e7bA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1E7B_B_HLTB4003_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 6 ASN A 390
PHE A 402
GLY A 433
LEU A 452
 None
 0.73A 1e7bB-5dqfA:
46.6		 1e7bB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1E7B_B_HLTB4003_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 6 ASN A 390
PHE A 402
VAL A 432
GLY A 433
 None
 0.49A 1e7bB-5dqfA:
46.6		 1e7bB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1E7C_A_HLTA4004_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 4 VAL A 215
PHE A 227
SER A 231
VAL A 234
 None
 0.41A 1e7cA-5dqfA:
40.7		 1e7cA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1H9Z_A_RWFA3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 11 TRP A 213
LEU A 218
LEU A 237
HIS A 241
ARG A 256
LEU A 259
SER A 286
ALA A 290
 None
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 ( 4.5A)
PG4  A 602 (-3.9A)
PG4  A 602 (-3.4A)
 0.71A 1h9zA-5dqfA:
42.6		 1h9zA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HA2_A_SWFA3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 11 TRP A 213
LEU A 218
LEU A 237
HIS A 241
LEU A 259
SER A 286
ILE A 289
ALA A 290
 None
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 ( 4.5A)
PG4  A 602 (-3.9A)
PG4  A 602 ( 4.4A)
PG4  A 602 (-3.4A)
 0.62A 1ha2A-5dqfA:
43.1		 1ha2A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK1_A_T44A3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 11 TYR A 149
ARG A 217
LEU A 218
LEU A 237
HIS A 241
ARG A 256
ALA A 290
 PG4  A 602 (-4.9A)
CL  A 617 ( 4.6A)
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 (-3.4A)
 1.01A 1hk1A-5dqfA:
46.4		 1hk1A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK1_A_T44A3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 11 TYR A 149
LEU A 218
ARG A 217
LEU A 237
ARG A 256
ALA A 290
 PG4  A 602 (-4.9A)
None
CL  A 617 ( 4.6A)
PG4  A 602 (-4.7A)
PG4  A 602 (-4.1A)
PG4  A 602 (-3.4A)
 1.31A 1hk1A-5dqfA:
46.4		 1hk1A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK1_A_T44A3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 11 TYR A 149
LYS A 198
ARG A 217
LEU A 237
HIS A 241
ARG A 256
ALA A 290
 PG4  A 602 (-4.9A)
PG4  A 602 ( 4.3A)
CL  A 617 ( 4.6A)
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 (-3.4A)
 1.16A 1hk1A-5dqfA:
46.4		 1hk1A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK1_A_T44A3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 11 TYR A 149
LYS A 198
TRP A 213
LEU A 237
HIS A 241
ARG A 256
ALA A 290
 PG4  A 602 (-4.9A)
PG4  A 602 ( 4.3A)
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 (-3.4A)
 0.76A 1hk1A-5dqfA:
46.4		 1hk1A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK1_A_T44A3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 11 TYR A 149
TRP A 213
LEU A 218
LEU A 237
HIS A 241
ARG A 256
ALA A 290
 PG4  A 602 (-4.9A)
None
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 (-3.4A)
 0.42A 1hk1A-5dqfA:
46.4		 1hk1A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK1_A_T44A3002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 9 ASN A 390
LEU A 393
LEU A 406
TYR A 410
LEU A 452
SER A 488
 None
 1.14A 1hk1A-5dqfA:
46.4		 1hk1A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK1_A_T44A3002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 9 LEU A 393
LEU A 406
TYR A 410
LYS A 413
LEU A 452
SER A 488
 None
 0.70A 1hk1A-5dqfA:
46.4		 1hk1A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK1_A_T44A3003_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 6 ILE A 512
LYS A 523
ALA A 527
VAL A 554
 None
 1.05A 1hk1A-5dqfA:
46.4		 1hk1A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK2_A_T44A3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 9 TYR A 149
LEU A 218
LEU A 237
HIS A 241
ARG A 256
ALA A 290
 PG4  A 602 (-4.9A)
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 (-3.4A)
 0.58A 1hk2A-5dqfA:
49.1		 1hk2A-5dqfA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK2_A_T44A3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 TYR A 149
LYS A 198
HIS A 241
ARG A 256
ALA A 290
 PG4  A 602 (-4.9A)
PG4  A 602 ( 4.3A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 (-3.4A)
 0.74A 1hk2A-5dqfA:
49.1		 1hk2A-5dqfA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK2_A_T44A3002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 8 ASN A 390
LEU A 393
LEU A 406
TYR A 410
SER A 488
 None
 1.12A 1hk2A-5dqfA:
49.1		 1hk2A-5dqfA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK2_A_T44A3002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 8 LEU A 393
LEU A 406
LEU A 452
SER A 488
 None
 0.79A 1hk2A-5dqfA:
49.1		 1hk2A-5dqfA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK2_A_T44A3002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 8 LEU A 393
LEU A 406
TYR A 410
LYS A 413
SER A 488
 None
 0.55A 1hk2A-5dqfA:
49.1		 1hk2A-5dqfA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK3_A_T44A3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 11 TYR A 149
LEU A 218
ARG A 217
LEU A 237
ARG A 256
ALA A 290
 PG4  A 602 (-4.9A)
None
CL  A 617 ( 4.6A)
PG4  A 602 (-4.7A)
PG4  A 602 (-4.1A)
PG4  A 602 (-3.4A)
 1.41A 1hk3A-5dqfA:
45.9		 1hk3A-5dqfA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK3_A_T44A3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 11 TYR A 149
LYS A 194
TRP A 213
LEU A 218
LEU A 237
HIS A 241
ARG A 256
ALA A 290
 PG4  A 602 (-4.9A)
CL  A 617 ( 4.0A)
None
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 (-3.4A)
 0.75A 1hk3A-5dqfA:
45.9		 1hk3A-5dqfA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK3_A_T44A3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 11 TYR A 149
LYS A 198
TRP A 213
HIS A 241
ARG A 256
ALA A 290
 PG4  A 602 (-4.9A)
PG4  A 602 ( 4.3A)
None
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 (-3.4A)
 0.86A 1hk3A-5dqfA:
45.9		 1hk3A-5dqfA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK3_A_T44A3002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 8 ASN A 390
LEU A 406
TYR A 410
SER A 488
 None
 1.12A 1hk3A-5dqfA:
45.9		 1hk3A-5dqfA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK3_A_T44A3002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 8 LEU A 406
TYR A 410
LEU A 452
SER A 488
 None
 0.85A 1hk3A-5dqfA:
45.9		 1hk3A-5dqfA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK3_A_T44A3002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 8 LEU A 406
TYR A 410
LYS A 413
SER A 488
 None
 0.54A 1hk3A-5dqfA:
45.9		 1hk3A-5dqfA:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HK3_A_T44A3004_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 7 GLU A 152
LEU A 153
VAL A 141
LEU A 189
 None
 1.01A 1hk3A-5dqfA:
45.9		 1hk3A-5dqfA:
76.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HWI_A_115A2_2
(HMG-COA REDUCTASE)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 8 ASN A 390
LEU A 452
ALA A 455
LEU A 456
 None
 0.71A 1hwiB-5dqfA:
undetectable		 1hwiB-5dqfA:
22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HWI_D_115D3_1
(HMG-COA REDUCTASE)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 8 ASN A 390
LEU A 452
ALA A 455
LEU A 456
 None
 0.69A 1hwiC-5dqfA:
undetectable		 1hwiC-5dqfA:
22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1S9P_C_DESC500_1
(ESTROGEN-RELATED
RECEPTOR GAMMA)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 12 LEU A 462
LEU A 459
LEU A 456
ALA A 455
LEU A 429
 None
 1.04A 1s9pC-5dqfA:
undetectable		 1s9pC-5dqfA:
18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T7I_A_017A200_2
(POL POLYPROTEIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 7 ALA A 405
ASP A 401
GLY A 426
ILE A 425
 None
CL  A 615 ( 3.8A)
None
None
 0.81A 1t7iB-5dqfA:
undetectable		 1t7iB-5dqfA:
11.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T7J_A_478A200_2
(POL POLYPROTEIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 7 ALA A 405
ASP A 401
GLY A 426
ILE A 425
 None
CL  A 615 ( 3.8A)
None
None
 0.83A 1t7jB-5dqfA:
undetectable		 1t7jB-5dqfA:
11.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXC_A_P1ZA2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 12 SER A 191
LEU A 218
ILE A 263
ILE A 289
ALA A 290
 None
None
None
PG4  A 602 ( 4.4A)
PG4  A 602 (-3.4A)
 1.05A 2bxcA-5dqfA:
46.3		 2bxcA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXC_A_P1ZA2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		10 / 12 TYR A 149
LYS A 198
LEU A 218
LEU A 237
HIS A 241
ARG A 256
ALA A 260
ILE A 263
ILE A 289
ALA A 290
 PG4  A 602 (-4.9A)
PG4  A 602 ( 4.3A)
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 ( 3.9A)
None
PG4  A 602 ( 4.4A)
PG4  A 602 (-3.4A)
 0.73A 2bxcA-5dqfA:
46.3		 2bxcA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXC_A_P1ZA2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		10 / 12 TYR A 149
SER A 191
LEU A 218
LEU A 237
HIS A 241
ARG A 256
ALA A 260
ILE A 263
ILE A 289
ALA A 290
 PG4  A 602 (-4.9A)
None
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 ( 3.9A)
None
PG4  A 602 ( 4.4A)
PG4  A 602 (-3.4A)
 0.51A 2bxcA-5dqfA:
46.3		 2bxcA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXC_B_P1ZB2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 9 TYR A 149
GLU A 152
LEU A 218
LEU A 237
HIS A 241
ARG A 256
ALA A 260
ALA A 290
 PG4  A 602 (-4.9A)
None
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 ( 3.9A)
PG4  A 602 (-3.4A)
 0.51A 2bxcB-5dqfA:
46.4		 2bxcB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXC_B_P1ZB2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 9 TYR A 149
GLU A 152
LEU A 237
HIS A 241
ARG A 256
ALA A 257
 PG4  A 602 (-4.9A)
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
None
 1.22A 2bxcB-5dqfA:
46.4		 2bxcB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXD_A_RWFA2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 9 TYR A 149
LYS A 198
LEU A 237
HIS A 241
ARG A 256
LEU A 259
ALA A 290
 PG4  A 602 (-4.9A)
PG4  A 602 ( 4.3A)
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 ( 4.5A)
PG4  A 602 (-3.4A)
 0.68A 2bxdA-5dqfA:
47.0		 2bxdA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXD_B_RWFB2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 10 TYR A 149
LYS A 198
TRP A 213
LEU A 237
HIS A 241
ILE A 289
ALA A 290
 PG4  A 602 (-4.9A)
PG4  A 602 ( 4.3A)
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 ( 4.4A)
PG4  A 602 (-3.4A)
 0.65A 2bxdB-5dqfA:
47.0		 2bxdB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXE_A_1FLA2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		9 / 11 LEU A 386
ASN A 390
ARG A 409
TYR A 410
LYS A 413
VAL A 432
GLY A 433
LEU A 452
SER A 488
 None
 0.75A 2bxeA-5dqfA:
46.1		 2bxeA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXE_A_1FLA2002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		9 / 10 PHE A 205
ALA A 209
ALA A 212
LEU A 330
LEU A 346
ALA A 349
GLU A 353
SER A 479
LEU A 480
 None
CZE  A 613 ( 4.4A)
CZE  A 613 ( 3.7A)
CZE  A 613 ( 4.2A)
CZE  A 613 ( 3.8A)
CZE  A 613 ( 4.7A)
CZE  A 613 (-2.9A)
None
None
 0.64A 2bxeA-5dqfA:
46.1		 2bxeA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXE_A_1FLA2003_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 9 TYR A 149
LEU A 218
PHE A 222
LEU A 237
HIS A 241
ARG A 256
LEU A 259
ALA A 290
 PG4  A 602 (-4.9A)
None
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 ( 4.5A)
PG4  A 602 (-3.4A)
 0.44A 2bxeA-5dqfA:
46.1		 2bxeA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXE_B_1FLB2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 12 LEU A 386
ASN A 390
PHE A 402
TYR A 410
LYS A 413
GLY A 433
LEU A 452
SER A 488
 None
 0.65A 2bxeB-5dqfA:
48.1		 2bxeB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXE_B_1FLB2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 12 LEU A 386
ASN A 390
PHE A 402
TYR A 410
LYS A 413
VAL A 432
GLY A 433
SER A 488
 None
 0.52A 2bxeB-5dqfA:
48.1		 2bxeB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXE_B_1FLB2002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		9 / 11 PHE A 205
ALA A 209
ALA A 212
LEU A 346
ALA A 349
LYS A 350
GLU A 353
SER A 479
LEU A 480
 None
CZE  A 613 ( 4.4A)
CZE  A 613 ( 3.7A)
CZE  A 613 ( 3.8A)
CZE  A 613 ( 4.7A)
CZE  A 613 (-4.1A)
CZE  A 613 (-2.9A)
None
None
 0.72A 2bxeB-5dqfA:
48.1		 2bxeB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXE_B_1FLB2003_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		9 / 10 TYR A 149
LEU A 218
PHE A 222
LEU A 237
HIS A 241
ARG A 256
LEU A 259
ILE A 263
ALA A 290
 PG4  A 602 (-4.9A)
None
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 ( 4.5A)
None
PG4  A 602 (-3.4A)
 0.43A 2bxeB-5dqfA:
48.1		 2bxeB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXF_A_DZPA2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		9 / 12 ASN A 390
PHE A 402
LEU A 406
TYR A 410
LEU A 429
VAL A 432
GLU A 449
LEU A 452
ARG A 484
 None
 0.69A 2bxfA-5dqfA:
46.5		 2bxfA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXF_B_DZPB2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 12 ASN A 390
PHE A 402
TYR A 410
LEU A 429
VAL A 432
GLU A 449
LEU A 452
ARG A 484
 None
 0.78A 2bxfB-5dqfA:
50.1		 2bxfB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXF_B_DZPB2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 12 LEU A 386
ASN A 390
PHE A 402
TYR A 410
VAL A 432
GLU A 449
ARG A 484
 None
 0.73A 2bxfB-5dqfA:
50.1		 2bxfB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXG_A_IBPA2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		9 / 11 LEU A 386
ASN A 390
ARG A 409
TYR A 410
LYS A 413
VAL A 432
GLY A 433
ARG A 484
SER A 488
 None
 0.68A 2bxgA-5dqfA:
48.9		 2bxgA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXG_A_IBPA2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 11 LEU A 386
ASN A 390
LYS A 413
VAL A 432
GLY A 433
LEU A 452
ARG A 484
SER A 488
 None
 0.64A 2bxgA-5dqfA:
48.9		 2bxgA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXG_A_IBPA2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 11 LEU A 386
ASN A 390
VAL A 432
GLY A 430
LEU A 452
ARG A 484
SER A 488
 None
 1.47A 2bxgA-5dqfA:
48.9		 2bxgA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXG_A_IBPA2002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 8 ALA A 212
ALA A 349
GLU A 353
SER A 479
LEU A 480
 CZE  A 613 ( 3.7A)
CZE  A 613 ( 4.7A)
CZE  A 613 (-2.9A)
None
None
 0.76A 2bxgA-5dqfA:
48.9		 2bxgA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXG_A_IBPA2002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 8 ALA A 349
LYS A 350
GLU A 353
SER A 479
LEU A 480
 CZE  A 613 ( 4.7A)
CZE  A 613 (-4.1A)
CZE  A 613 (-2.9A)
None
None
 0.87A 2bxgA-5dqfA:
48.9		 2bxgA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXG_B_IBPB2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 9 ASN A 390
ARG A 409
TYR A 410
LYS A 413
GLY A 433
SER A 488
 None
 0.61A 2bxgB-5dqfA:
49.6		 2bxgB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXG_B_IBPB2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 ASN A 390
GLY A 430
LEU A 452
ARG A 484
SER A 488
 None
 1.24A 2bxgB-5dqfA:
49.6		 2bxgB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXG_B_IBPB2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 9 ASN A 390
LYS A 413
GLY A 433
LEU A 452
ARG A 484
SER A 488
 None
 0.66A 2bxgB-5dqfA:
49.6		 2bxgB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXG_B_IBPB2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 9 ASN A 390
TYR A 410
LYS A 413
GLY A 433
ARG A 484
SER A 488
 None
 0.42A 2bxgB-5dqfA:
49.6		 2bxgB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXG_B_IBPB2002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 10 ALA A 209
ALA A 212
LEU A 330
LEU A 346
ALA A 349
SER A 479
LEU A 480
 CZE  A 613 ( 4.4A)
CZE  A 613 ( 3.7A)
CZE  A 613 ( 4.2A)
CZE  A 613 ( 3.8A)
CZE  A 613 ( 4.7A)
None
None
 0.60A 2bxgB-5dqfA:
49.6		 2bxgB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXG_B_IBPB2002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 10 ALA A 209
LEU A 330
LEU A 346
ALA A 349
LYS A 350
SER A 479
LEU A 480
 CZE  A 613 ( 4.4A)
CZE  A 613 ( 4.2A)
CZE  A 613 ( 3.8A)
CZE  A 613 ( 4.7A)
CZE  A 613 (-4.1A)
None
None
 0.88A 2bxgB-5dqfA:
49.6		 2bxgB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXG_B_IBPB2002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 10 ARG A 208
ALA A 209
ALA A 212
LEU A 330
LEU A 346
 CZE  A 613 ( 3.5A)
CZE  A 613 ( 4.4A)
CZE  A 613 ( 3.7A)
CZE  A 613 ( 4.2A)
CZE  A 613 ( 3.8A)
 0.83A 2bxgB-5dqfA:
49.6		 2bxgB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXP_A_P1ZA3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		9 / 12 TRP A 213
LEU A 218
PHE A 222
LEU A 237
HIS A 241
LEU A 259
ALA A 260
ILE A 263
ALA A 290
 None
None
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 ( 4.5A)
PG4  A 602 ( 3.9A)
None
PG4  A 602 (-3.4A)
 0.56A 2bxpA-5dqfA:
41.4		 2bxpA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXP_A_P1ZA3001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		9 / 12 TRP A 213
LEU A 218
PHE A 222
LEU A 237
HIS A 241
LEU A 259
ILE A 263
SER A 286
ALA A 290
 None
None
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 ( 4.5A)
None
PG4  A 602 (-3.9A)
PG4  A 602 (-3.4A)
 0.71A 2bxpA-5dqfA:
41.4		 2bxpA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXQ_A_IMNA2001_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 10 ALA A 209
ARG A 217
LEU A 218
LEU A 237
LEU A 480
 CZE  A 613 ( 4.4A)
CL  A 617 ( 4.6A)
None
PG4  A 602 (-4.7A)
None
 0.53A 2bxqA-5dqfA:
41.5		 2bxqA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXQ_A_P1ZA2002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		10 / 12 LEU A 218
PHE A 222
LEU A 237
HIS A 241
ARG A 256
LEU A 259
ILE A 263
SER A 286
ILE A 289
ALA A 290
 None
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 (-4.1A)
PG4  A 602 ( 4.5A)
None
PG4  A 602 (-3.9A)
PG4  A 602 ( 4.4A)
PG4  A 602 (-3.4A)
 0.62A 2bxqA-5dqfA:
41.5		 2bxqA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BXQ_A_P1ZA2002_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 12 LYS A 198
HIS A 241
ILE A 263
SER A 286
ILE A 289
ALA A 290
 PG4  A 602 ( 4.3A)
PG4  A 602 (-4.0A)
None
PG4  A 602 (-3.9A)
PG4  A 602 ( 4.4A)
PG4  A 602 (-3.4A)
 1.21A 2bxqA-5dqfA:
41.5		 2bxqA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2I2Z_A_SALA1100_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 5 LEU A 218
LEU A 259
ILE A 263
ILE A 289
ALA A 290
 None
PG4  A 602 ( 4.5A)
None
PG4  A 602 ( 4.4A)
PG4  A 602 (-3.4A)
 0.35A 2i2zA-5dqfA:
42.1		 2i2zA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2I30_A_SALA1200_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 4 LEU A 218
ILE A 263
ILE A 289
ALA A 290
 None
None
PG4  A 602 ( 4.4A)
PG4  A 602 (-3.4A)
 0.38A 2i30A-5dqfA:
42.5		 2i30A-5dqfA:
76.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IZQ_A_DVAA6_0
(GRAMICIDIN D)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		3 / 3 ALA A 481
VAL A 342
TRP A 213
 CZE  A 613 ( 4.6A)
None
None
 0.97A 2izqA-5dqfA:
undetectable
2izqB-5dqfA:
undetectable		 2izqA-5dqfA:
2.29
2izqB-5dqfA:
2.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3B9M_A_SALA1100_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 4 LEU A 218
ARG A 256
LEU A 259
ALA A 290
 None
PG4  A 602 (-4.1A)
PG4  A 602 ( 4.5A)
PG4  A 602 (-3.4A)
 0.60A 3b9mA-5dqfA:
38.6		 3b9mA-5dqfA:
76.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IJX_H_HCZH800_1
(GLUTAMATE RECEPTOR 2)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 5 PRO A 338
SER A 442
LEU A 345
SER A 341
 None
 1.50A 3ijxH-5dqfA:
undetectable		 3ijxH-5dqfA:
18.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KP5_B_KANB2002_1
(TRANSCRIPTIONAL
REGULATOR TCAR)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		3 / 3 ALA A 405
ARG A 409
LYS A 413
 None
 0.71A 3kp5B-5dqfA:
undetectable		 3kp5B-5dqfA:
13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MZE_A_CFXA364_2
(D-ALANYL-D-ALANINE
CARBOXYPEPTIDASE
DACA)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		3 / 3 SER A 201
SER A 200
HIS A 246
 None
 0.77A 3mzeA-5dqfA:
undetectable		 3mzeA-5dqfA:
20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R9V_B_DXCB323_0
(INVASIN IPAD)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 7 ILE A 233
VAL A 215
LEU A 218
SER A 219
 None
 0.55A 3r9vA-5dqfA:
undetectable
3r9vB-5dqfA:
undetectable		 3r9vA-5dqfA:
18.73
3r9vB-5dqfA:
18.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W9T_B_W9TB504_1
(HEMOLYTIC LECTIN
CEL-III)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 5 GLU A 494
GLY A 495
TYR A 496
GLN A 416
 None
 1.42A 3w9tB-5dqfA:
undetectable		 3w9tB-5dqfA:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W9T_D_W9TD506_1
(HEMOLYTIC LECTIN
CEL-III)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 5 GLU A 494
GLY A 495
TYR A 496
GLN A 416
 None
 1.41A 3w9tD-5dqfA:
undetectable		 3w9tD-5dqfA:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W9T_G_W9TG505_1
(HEMOLYTIC LECTIN
CEL-III)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 5 GLU A 494
GLY A 495
TYR A 496
GLN A 416
 None
 1.41A 3w9tG-5dqfA:
undetectable		 3w9tG-5dqfA:
20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_A_ZPCA1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 7 GLU A 229
PHE A 222
TYR A 262
VAL A 240
 None
 0.90A 4a97A-5dqfA:
3.1		 4a97A-5dqfA:
19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_D_ZPCD1318_2
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 7 GLU A 229
PHE A 222
TYR A 262
VAL A 240
 None
 1.03A 4a97D-5dqfA:
3.1		 4a97D-5dqfA:
19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_E_ZPCE1318_2
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 6 GLU A 229
PHE A 222
TYR A 262
VAL A 240
 None
 0.88A 4a97E-5dqfA:
3.2		 4a97E-5dqfA:
19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AC9_C_DXCC1480_0
(MJ0495-LIKE PROTEIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 4 LYS A 221
GLU A 229
ILE A 270
SER A 271
 CL  A 617 (-3.4A)
None
None
None
 1.27A 4ac9C-5dqfA:
undetectable		 4ac9C-5dqfA:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ACA_C_DXCC1480_0
(TRANSLATION
ELONGATION FACTOR
SELB)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 4 LYS A 221
GLU A 229
ILE A 270
SER A 271
 CL  A 617 (-3.4A)
None
None
None
 1.26A 4acaC-5dqfA:
undetectable		 4acaC-5dqfA:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ACB_C_DXCC1480_0
(TRANSLATION
ELONGATION FACTOR
SELB)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 4 LYS A 221
GLU A 229
ILE A 270
SER A 271
 CL  A 617 (-3.4A)
None
None
None
 1.32A 4acbC-5dqfA:
undetectable		 4acbC-5dqfA:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E1G_B_LNLB701_2
(PROSTAGLANDIN G/H
SYNTHASE 2)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 7 VAL A 230
VAL A 234
LEU A 237
VAL A 210
 None
None
PG4  A 602 (-4.7A)
None
 1.06A 4e1gB-5dqfA:
5.0		 4e1gB-5dqfA:
21.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L9Q_A_9TPA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 12 ALA A 125
TYR A 137
HIS A 145
TYR A 160
LEU A 181
 None
 0.35A 4l9qA-5dqfA:
50.5		 4l9qA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L9Q_B_9TPB601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 12 ALA A 125
TYR A 137
HIS A 145
TYR A 160
LEU A 181
LEU A 184
 None
 0.65A 4l9qB-5dqfA:
48.7		 4l9qB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LA0_A_198A601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 10 ALA A 125
PHE A 133
GLU A 140
PHE A 164
LEU A 181
 None
 0.51A 4la0A-5dqfA:
50.6		 4la0A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LA0_B_198B601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 ALA A 125
PHE A 133
GLU A 140
PHE A 164
LEU A 181
 None
 0.49A 4la0B-5dqfA:
47.4		 4la0B-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LUH_A_ACTA610_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		3 / 3 VAL A 417
SER A 418
THR A 421
 None
 0.14A 4luhA-5dqfA:
47.8		 4luhA-5dqfA:
75.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_A_NPSA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 11 ASN A 390
PHE A 402
ARG A 409
LYS A 413
VAL A 432
GLY A 433
LEU A 452
SER A 488
 None
 0.83A 4or0A-5dqfA:
50.6		 4or0A-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_A_NPSA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 11 ASN A 390
PHE A 402
ARG A 409
TYR A 410
LYS A 413
VAL A 432
GLY A 433
SER A 488
 None
 0.73A 4or0A-5dqfA:
50.6		 4or0A-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_A_NPSA602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 ALA A 209
ALA A 212
LEU A 326
SER A 479
LEU A 480
 CZE  A 613 ( 4.4A)
CZE  A 613 ( 3.7A)
CZE  A 613 ( 4.7A)
None
None
 1.02A 4or0A-5dqfA:
50.6		 4or0A-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_A_NPSA602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 ALA A 209
LEU A 326
LYS A 350
SER A 479
LEU A 480
 CZE  A 613 ( 4.4A)
CZE  A 613 ( 4.7A)
CZE  A 613 (-4.1A)
None
None
 1.13A 4or0A-5dqfA:
50.6		 4or0A-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_A_NPSA602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 PHE A 205
ALA A 209
ALA A 212
SER A 479
LEU A 480
 None
CZE  A 613 ( 4.4A)
CZE  A 613 ( 3.7A)
None
None
 0.89A 4or0A-5dqfA:
50.6		 4or0A-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_A_NPSA602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 PHE A 205
ARG A 208
ALA A 209
ALA A 212
LEU A 480
 None
CZE  A 613 ( 3.5A)
CZE  A 613 ( 4.4A)
CZE  A 613 ( 3.7A)
None
 0.90A 4or0A-5dqfA:
50.6		 4or0A-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_A_NPSA603_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 11 LEU A 197
SER A 201
LEU A 346
LEU A 454
LEU A 480
 None
None
CZE  A 613 ( 3.8A)
None
None
 0.95A 4or0A-5dqfA:
undetectable		 4or0A-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_B_NPSB601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 10 ASN A 390
PHE A 402
ARG A 409
LYS A 413
VAL A 432
LEU A 452
SER A 488
 None
 0.79A 4or0B-5dqfA:
50.2		 4or0B-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_B_NPSB601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 10 ASN A 390
PHE A 402
ARG A 409
TYR A 410
LYS A 413
VAL A 432
SER A 488
 None
 0.63A 4or0B-5dqfA:
50.2		 4or0B-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_B_NPSB602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 ALA A 209
ALA A 212
LEU A 346
SER A 479
LEU A 480
 CZE  A 613 ( 4.4A)
CZE  A 613 ( 3.7A)
CZE  A 613 ( 3.8A)
None
None
 0.85A 4or0B-5dqfA:
50.2		 4or0B-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_B_NPSB602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 ALA A 209
LEU A 346
LYS A 350
SER A 479
LEU A 480
 CZE  A 613 ( 4.4A)
CZE  A 613 ( 3.8A)
CZE  A 613 (-4.1A)
None
None
 1.08A 4or0B-5dqfA:
50.2		 4or0B-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_B_NPSB602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 ALA A 212
LEU A 326
LEU A 346
SER A 479
LEU A 480
 CZE  A 613 ( 3.7A)
CZE  A 613 ( 4.7A)
CZE  A 613 ( 3.8A)
None
None
 0.97A 4or0B-5dqfA:
50.2		 4or0B-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_B_NPSB602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 ARG A 208
ALA A 209
ALA A 212
LEU A 346
LEU A 480
 CZE  A 613 ( 3.5A)
CZE  A 613 ( 4.4A)
CZE  A 613 ( 3.7A)
CZE  A 613 ( 3.8A)
None
 0.92A 4or0B-5dqfA:
50.2		 4or0B-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_B_NPSB602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 LEU A 326
LEU A 346
LYS A 350
SER A 479
LEU A 480
 CZE  A 613 ( 4.7A)
CZE  A 613 ( 3.8A)
CZE  A 613 (-4.1A)
None
None
 1.02A 4or0B-5dqfA:
50.2		 4or0B-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_B_NPSB603_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 11 LEU A 197
SER A 201
VAL A 342
LEU A 346
LEU A 454
LEU A 480
 None
None
None
CZE  A 613 ( 3.8A)
None
None
 0.95A 4or0B-5dqfA:
50.2		 4or0B-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OR0_B_NPSB603_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 11 SER A 201
VAL A 342
SER A 343
LEU A 346
LEU A 480
 None
None
None
CZE  A 613 ( 3.8A)
None
 0.90A 4or0B-5dqfA:
50.2		 4or0B-5dqfA:
73.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OT2_A_ACTA605_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		3 / 3 LYS A 194
LYS A 221
ALA A 290
 CL  A 617 ( 4.0A)
CL  A 617 (-3.4A)
PG4  A 602 (-3.4A)
 0.65A 4ot2A-5dqfA:
54.7		 4ot2A-5dqfA:
99.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OT2_A_NPSA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 12 LEU A 386
ASN A 390
PHE A 402
GLY A 430
LEU A 452
SER A 488
 None
 1.47A 4ot2A-5dqfA:
54.7		 4ot2A-5dqfA:
99.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OT2_A_NPSA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 12 LEU A 386
ASN A 390
PHE A 402
LYS A 413
GLY A 433
SER A 448
LEU A 452
SER A 488
 None
 0.52A 4ot2A-5dqfA:
54.7		 4ot2A-5dqfA:
99.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OT2_A_NPSA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		9 / 12 LEU A 386
ASN A 390
PHE A 402
TYR A 410
LYS A 413
VAL A 432
GLY A 433
SER A 448
SER A 488
 None
 0.39A 4ot2A-5dqfA:
54.7		 4ot2A-5dqfA:
99.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OT2_A_NPSA602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 6 ALA A 212
ASP A 323
LEU A 346
LYS A 350
 CZE  A 613 ( 3.7A)
CZE  A 613 ( 4.7A)
CZE  A 613 ( 3.8A)
CZE  A 613 (-4.1A)
 1.05A 4ot2A-5dqfA:
54.7		 4ot2A-5dqfA:
99.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OT2_A_NPSA602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 6 ALA A 212
ASP A 323
LEU A 346
SER A 479
 CZE  A 613 ( 3.7A)
CZE  A 613 ( 4.7A)
CZE  A 613 ( 3.8A)
None
 0.61A 4ot2A-5dqfA:
54.7		 4ot2A-5dqfA:
99.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OT2_A_NPSA602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 6 ARG A 208
ALA A 212
LEU A 346
SER A 479
 CZE  A 613 ( 3.5A)
CZE  A 613 ( 3.7A)
CZE  A 613 ( 3.8A)
None
 0.94A 4ot2A-5dqfA:
54.7		 4ot2A-5dqfA:
99.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PO0_A_NPSA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 12 VAL A 387
ASN A 390
PHE A 402
ARG A 409
LYS A 413
LEU A 452
ARG A 484
SER A 488
 None
 0.73A 4po0A-5dqfA:
50.0		 4po0A-5dqfA:
71.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PO0_A_NPSA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 12 VAL A 387
ASN A 390
PHE A 402
ARG A 409
TYR A 410
LYS A 413
ARG A 484
SER A 488
 None
 0.64A 4po0A-5dqfA:
50.0		 4po0A-5dqfA:
71.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PO0_A_NPSA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 12 VAL A 387
ASN A 390
PHE A 402
LEU A 406
ARG A 409
LEU A 452
ARG A 484
SER A 488
 None
 0.61A 4po0A-5dqfA:
50.0		 4po0A-5dqfA:
71.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PO0_A_NPSA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 12 VAL A 387
ASN A 390
PHE A 402
LEU A 406
ARG A 409
TYR A 410
ARG A 484
SER A 488
 None
 0.48A 4po0A-5dqfA:
50.0		 4po0A-5dqfA:
71.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4PO0_A_NPSA603_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 10 LEU A 393
ASN A 404
VAL A 408
LEU A 528
LEU A 543
 None
 0.65A 4po0A-5dqfA:
50.0		 4po0A-5dqfA:
71.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QA0_A_SHHA404_1
(HISTONE DEACETYLASE
8)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 12 GLY A  71
PHE A  70
HIS A  67
ASP A 248
GLY A 247
 None
PG4  A 605 (-4.6A)
None
PG4  A 605 (-4.5A)
None
 1.28A 4qa0A-5dqfA:
undetectable		 4qa0A-5dqfA:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UHX_A_LZUA3008_1
(ALDEHYDE OXIDASE)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 8 GLU A 449
SER A 488
ARG A 409
PRO A 485
 None
 1.00A 4uhxA-5dqfA:
undetectable		 4uhxA-5dqfA:
18.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UHX_A_RTZA3009_1
(ALDEHYDE OXIDASE)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 8 GLU A 449
SER A 488
ARG A 409
PRO A 485
 None
 1.00A 4uhxA-5dqfA:
undetectable		 4uhxA-5dqfA:
18.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z69_A_DIFA1007_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 LEU A 218
LEU A 259
ILE A 263
SER A 286
ALA A 290
 None
PG4  A 602 ( 4.5A)
None
PG4  A 602 (-3.9A)
PG4  A 602 (-3.4A)
 0.56A 4z69A-5dqfA:
38.4		 4z69A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z69_A_DIFA1007_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 LYS A 198
LEU A 259
ILE A 263
SER A 286
ALA A 290
 PG4  A 602 ( 4.3A)
PG4  A 602 ( 4.5A)
None
PG4  A 602 (-3.9A)
PG4  A 602 (-3.4A)
 0.94A 4z69A-5dqfA:
38.4		 4z69A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z69_A_DIFA1007_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 LYS A 198
TRP A 213
LEU A 259
ILE A 263
ALA A 290
 PG4  A 602 ( 4.3A)
None
PG4  A 602 ( 4.5A)
None
PG4  A 602 (-3.4A)
 1.17A 4z69A-5dqfA:
38.4		 4z69A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z69_A_DIFA1007_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 TRP A 213
ARG A 217
LEU A 218
LEU A 259
ILE A 263
 None
CL  A 617 ( 4.6A)
None
PG4  A 602 ( 4.5A)
None
 1.14A 4z69A-5dqfA:
38.4		 4z69A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z69_A_DIFA1007_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 9 TRP A 213
LEU A 218
LEU A 259
ILE A 263
ALA A 290
 None
None
PG4  A 602 ( 4.5A)
None
PG4  A 602 (-3.4A)
 0.79A 4z69A-5dqfA:
38.4		 4z69A-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z69_I_DIFI1006_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 10 LYS A 198
PHE A 222
ARG A 256
LEU A 259
ILE A 263
SER A 286
ALA A 290
 PG4  A 602 ( 4.3A)
None
PG4  A 602 (-4.1A)
PG4  A 602 ( 4.5A)
None
PG4  A 602 (-3.9A)
PG4  A 602 (-3.4A)
 0.88A 4z69I-5dqfA:
38.4		 4z69I-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z69_I_DIFI1006_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 10 LYS A 198
TRP A 213
PHE A 222
LEU A 259
ILE A 263
ALA A 290
 PG4  A 602 ( 4.3A)
None
None
PG4  A 602 ( 4.5A)
None
PG4  A 602 (-3.4A)
 1.09A 4z69I-5dqfA:
38.4		 4z69I-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z69_I_DIFI1006_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 10 TRP A 213
ARG A 217
PHE A 222
LEU A 259
ILE A 263
 None
CL  A 617 ( 4.6A)
None
PG4  A 602 ( 4.5A)
None
 1.18A 4z69I-5dqfA:
38.4		 4z69I-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZBQ_A_ACTA603_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 4 LYS A 194
TRP A 213
ARG A 217
ASN A 450
 CL  A 617 ( 4.0A)
None
CL  A 617 ( 4.6A)
None
 0.37A 4zbqA-5dqfA:
55.7		 4zbqA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZBQ_A_ACTA605_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 6 TYR A  30
HIS A  67
GLY A  71
GLU A  95
ARG A  98
ASN A  99
 None
 0.52A 4zbqA-5dqfA:
55.7		 4zbqA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZBQ_A_DIFA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 11 ASN A 390
PHE A 402
ARG A 409
GLY A 430
LEU A 452
ARG A 484
SER A 488
 None
 1.34A 4zbqA-5dqfA:
55.7		 4zbqA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZBQ_A_DIFA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 11 LEU A 386
ASN A 390
ARG A 409
GLY A 430
ARG A 484
SER A 488
 None
 1.12A 4zbqA-5dqfA:
55.7		 4zbqA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZBQ_A_DIFA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 11 LEU A 386
VAL A 387
ASN A 390
ARG A 409
SER A 448
ARG A 484
SER A 488
 None
 0.66A 4zbqA-5dqfA:
55.7		 4zbqA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZBQ_A_DIFA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		10 / 11 VAL A 387
ASN A 390
PHE A 402
LEU A 406
ARG A 409
GLY A 433
SER A 448
LEU A 452
ARG A 484
SER A 488
 None
 0.29A 4zbqA-5dqfA:
55.7		 4zbqA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZBR_A_ACTA608_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		3 / 3 LYS A 431
ARG A 435
HIS A 451
 PG4  A 604 (-2.9A)
None
None
 0.75A 4zbrA-5dqfA:
55.4		 4zbrA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZBR_A_DIFA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 9 LEU A 393
ASP A 401
ASN A 404
ALA A 405
VAL A 408
ARG A 409
LYS A 540
GLU A 541
 None
CL  A 615 ( 3.8A)
None
None
None
None
SO4  A 609 (-4.0A)
SO4  A 609 (-3.9A)
 0.52A 4zbrA-5dqfA:
55.4		 4zbrA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZBR_A_NPSA602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		10 / 12 LEU A 386
ASN A 390
PHE A 402
LEU A 406
TYR A 410
LYS A 413
GLY A 433
SER A 448
LEU A 452
SER A 488
 None
 0.48A 4zbrA-5dqfA:
55.4		 4zbrA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZBR_A_NPSA603_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 10 ALA A 212
ASP A 323
LEU A 326
LEU A 346
ALA A 349
SER A 479
LEU A 480
ALA A 481
 CZE  A 613 ( 3.7A)
CZE  A 613 ( 4.7A)
CZE  A 613 ( 4.7A)
CZE  A 613 ( 3.8A)
CZE  A 613 ( 4.7A)
None
None
CZE  A 613 ( 4.6A)
 0.40A 4zbrA-5dqfA:
55.4		 4zbrA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZBR_A_NPSA603_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 10 ARG A 208
ALA A 212
LEU A 346
SER A 479
LEU A 480
ALA A 481
 CZE  A 613 ( 3.5A)
CZE  A 613 ( 3.7A)
CZE  A 613 ( 3.8A)
None
None
CZE  A 613 ( 4.6A)
 0.83A 4zbrA-5dqfA:
55.4		 4zbrA-5dqfA:
99.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B8I_C_FK5C201_1
(SERINE/THREONINE-PRO
TEIN PHOSPHATASE
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 6 LEU A 345
SER A 219
PRO A 223
PHE A 222
 None
 1.30A 5b8iA-5dqfA:
undetectable		 5b8iA-5dqfA:
20.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5DBY_A_ACTA610_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		3 / 3 TYR A 496
LYS A 499
LYS A 533
 None
SO4  A 611 (-3.0A)
SO4  A 611 (-2.7A)
 0.14A 5dbyA-5dqfA:
54.7		 5dbyA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5DBY_A_ACTA612_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 4 SER A  65
HIS A  67
GLU A  95
PRO A  96
 None
 0.39A 5dbyA-5dqfA:
54.7		 5dbyA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5DBY_A_ACTA617_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		3 / 3 TRP A 213
ARG A 217
LEU A 237
 None
CL  A 617 ( 4.6A)
PG4  A 602 (-4.7A)
 0.16A 5dbyA-5dqfA:
54.7		 5dbyA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5DBY_A_DIFA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 9 LEU A 393
ASN A 404
ALA A 405
VAL A 408
ARG A 409
LYS A 540
 None
None
None
None
None
SO4  A 609 (-4.0A)
 0.47A 5dbyA-5dqfA:
54.7		 5dbyA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5DBY_A_DIFA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 9 LEU A 393
ASP A 401
ASN A 404
ALA A 405
VAL A 408
ARG A 409
 None
CL  A 615 ( 3.8A)
None
None
None
None
 0.20A 5dbyA-5dqfA:
54.7		 5dbyA-5dqfA:
99.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5DBY_A_NPSA602_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		10 / 12 LEU A 386
ASN A 390
PHE A 402
LEU A 406
ARG A 409
TYR A 410
LYS A 413
SER A 448
LEU A 452
SER A 488
 None
 0.47A 5dbyA-5dqfA:
54.7		 5dbyA-5dqfA:
99.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DZK_P_BEZP801_0
(ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT 2
BEZ-LEU-LEU)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 5 SER A 192
ALA A 193
HIS A 145
LEU A 189
 CL  A 614 (-3.2A)
None
None
None
 1.37A 5dzkb-5dqfA:
undetectable
5dzkp-5dqfA:
undetectable		 5dzkb-5dqfA:
16.98
5dzkp-5dqfA:
1.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DZK_Q_BEZQ801_0
(ATP-DEPENDENT CLP
PROTEASE PROTEOLYTIC
SUBUNIT 2
BEZ-LEU-LEU)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 5 SER A 192
ALA A 193
HIS A 145
LEU A 189
 CL  A 614 (-3.2A)
None
None
None
 1.37A 5dzkc-5dqfA:
undetectable
5dzkq-5dqfA:
undetectable		 5dzkc-5dqfA:
16.98
5dzkq-5dqfA:
1.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EB5_A_010A609_0
(HNL ISOENZYME 5)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 11 ARG A 435
ALA A 453
LEU A 454
LEU A 190
VAL A 432
 None
 1.32A 5eb5A-5dqfA:
undetectable		 5eb5A-5dqfA:
21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IKT_A_TLFA601_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		3 / 3 LEU A 452
TYR A 410
SER A 488
 None
 0.81A 5iktA-5dqfA:
undetectable		 5iktA-5dqfA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TRQ_B_ACTB306_0
(WELO5)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		3 / 3 GLU A 140
ARG A 143
TYR A 139
 None
 0.58A 5trqB-5dqfA:
undetectable		 5trqB-5dqfA:
18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TRQ_B_ACTB306_0
(WELO5)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		3 / 3 GLU A 332
ARG A 335
TYR A 331
 None
 0.36A 5trqB-5dqfA:
undetectable		 5trqB-5dqfA:
18.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 12 LYS A 194
GLU A 195
ARG A 256
LEU A 259
ILE A 289
ALA A 290
 CL  A 617 ( 4.0A)
None
PG4  A 602 (-4.1A)
PG4  A 602 ( 4.5A)
PG4  A 602 ( 4.4A)
PG4  A 602 (-3.4A)
 1.25A 5v0vA-5dqfA:
51.9		 5v0vA-5dqfA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 12 LYS A 194
LEU A 218
LEU A 237
ARG A 256
LEU A 259
ILE A 289
ALA A 290
GLU A 291
 CL  A 617 ( 4.0A)
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.1A)
PG4  A 602 ( 4.5A)
PG4  A 602 ( 4.4A)
PG4  A 602 (-3.4A)
CL  A 617 ( 4.4A)
 0.43A 5v0vA-5dqfA:
51.9		 5v0vA-5dqfA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		8 / 12 LYS A 194
LEU A 218
LEU A 237
HIS A 241
LEU A 259
ILE A 289
ALA A 290
GLU A 291
 CL  A 617 ( 4.0A)
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
PG4  A 602 ( 4.5A)
PG4  A 602 ( 4.4A)
PG4  A 602 (-3.4A)
CL  A 617 ( 4.4A)
 0.54A 5v0vA-5dqfA:
51.9		 5v0vA-5dqfA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5V0V_A_8QPA612_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 12 TYR A 149
LYS A 194
LEU A 218
LEU A 237
HIS A 241
GLU A 291
 PG4  A 602 (-4.9A)
CL  A 617 ( 4.0A)
None
PG4  A 602 (-4.7A)
PG4  A 602 (-4.0A)
CL  A 617 ( 4.4A)
 1.22A 5v0vA-5dqfA:
51.9		 5v0vA-5dqfA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A7P_A_9SCA601_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 12 LEU A 386
LEU A 422
GLY A 433
ARG A 484
PHE A 487
 None
 0.97A 6a7pA-5dqfA:
45.4		 6a7pA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A7P_A_9SCA601_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 12 LEU A 386
LEU A 422
GLY A 433
LEU A 452
ARG A 484
 None
 0.94A 6a7pA-5dqfA:
45.4		 6a7pA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A7P_A_9SCA601_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 12 LEU A 386
PHE A 402
LEU A 422
ARG A 484
PHE A 487
 None
 1.17A 6a7pA-5dqfA:
45.4		 6a7pA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A7P_A_9SCA601_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 12 LEU A 386
PHE A 402
LEU A 422
LEU A 452
ARG A 484
 None
 1.18A 6a7pA-5dqfA:
45.4		 6a7pA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A7P_A_9SCA601_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 12 LEU A 386
PHE A 402
VAL A 417
LEU A 452
ARG A 484
 None
 1.22A 6a7pA-5dqfA:
45.4		 6a7pA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A7P_A_9SCA601_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 12 LEU A 386
VAL A 417
GLY A 433
LEU A 452
ARG A 484
 None
 1.19A 6a7pA-5dqfA:
45.4		 6a7pA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A7P_A_9SCA601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 5 ASN A 390
TYR A 410
LEU A 459
SER A 488
 None
 1.10A 6a7pA-5dqfA:
45.4		 6a7pA-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A7P_B_9SCB601_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 12 LEU A 422
LEU A 459
ARG A 484
PHE A 487
LEU A 490
 None
 0.62A 6a7pB-5dqfA:
45.2		 6a7pB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A7P_B_9SCB601_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 12 LEU A 422
VAL A 432
LEU A 459
PHE A 487
LEU A 490
 None
 0.58A 6a7pB-5dqfA:
45.2		 6a7pB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A7P_B_9SCB601_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		5 / 12 LYS A 413
LEU A 422
VAL A 432
LEU A 459
LEU A 490
 None
 0.92A 6a7pB-5dqfA:
45.2		 6a7pB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6A7P_B_9SCB601_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 6 ASN A 390
PHE A 402
LEU A 452
SER A 488
 None
 1.29A 6a7pB-5dqfA:
45.2		 6a7pB-5dqfA:
76.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6CI6_A_NBOA606_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		10 / 12 ASN A 390
PHE A 402
ARG A 409
TYR A 410
LYS A 413
VAL A 432
GLY A 433
SER A 448
LEU A 452
SER A 488
 None
 0.50A 6ci6A-5dqfA:
51.9		 6ci6A-5dqfA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6CI6_A_NBOA607_1
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 7 ASP A 401
ASN A 404
ALA A 405
LYS A 540
GLU A 541
LEU A 547
 CL  A 615 ( 3.8A)
None
None
SO4  A 609 (-4.0A)
SO4  A 609 (-3.9A)
None
 0.52A 6ci6A-5dqfA:
51.9		 6ci6A-5dqfA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6MDQ_A_TESA604_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 8 LEU A 330
ALA A 349
LYS A 350
GLU A 353
 CZE  A 613 ( 4.2A)
CZE  A 613 ( 4.7A)
CZE  A 613 (-4.1A)
CZE  A 613 (-2.9A)
 0.69A 6mdqA-5dqfA:
55.4		 6mdqA-5dqfA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6MDQ_A_TESA604_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		4 / 8 LYS A  20
GLY A 135
LEU A 138
ALA A 157
 None
LCR  A 612 ( 3.8A)
None
LCR  A 612 ( 3.8A)
 0.62A 6mdqA-5dqfA:
55.4		 6mdqA-5dqfA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6MDQ_A_TESA604_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		6 / 8 LYS A 211
ALA A 212
GLY A 327
LEU A 330
ALA A 349
GLU A 353
 None
CZE  A 613 ( 3.7A)
CZE  A 613 (-3.5A)
CZE  A 613 ( 4.2A)
CZE  A 613 ( 4.7A)
CZE  A 613 (-2.9A)
 0.47A 6mdqA-5dqfA:
55.4		 6mdqA-5dqfA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6MDQ_A_TESA605_0
(SERUM ALBUMIN)		 5dqf SERUM ALBUMIN
(Equus
caballus) 		7 / 8 HIS A  18
LYS A  20
GLY A  21
LEU A 134
GLY A 135
LEU A 138
GLU A 158
 None
None
LCR  A 612 ( 4.0A)
LCR  A 612 ( 4.5A)
LCR  A 612 ( 3.8A)
None
None
 0.35A 6mdqA-5dqfA:
55.4		 6mdqA-5dqfA:
100.00